Blood-based biomarkers in Alzheimer disease: where are we now and where have we to go?
JAMA Neurol
.
2013 Jan;70(1):133.
doi: 10.1001/2013.jamaneurol.67.
Author
Christoph Laske
1
Affiliation
1
Section for Dementia Research, Hertie Institute for Clinical Brain Research, Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany. christoph.laske@med.uni-tuebingen.de
PMID:
23318524
DOI:
10.1001/2013.jamaneurol.67
No abstract available
Publication types
Comment
MeSH terms
Alzheimer Disease / blood*
Alzheimer Disease / diagnosis*
Biomarkers / blood*
Blood Proteins / metabolism*
Female
Gene Expression Regulation / physiology*
Humans
Male
Substances
Biomarkers
Blood Proteins